Carlos A. Zarate, M.D. is Chief of the Mood and Anxiety Disorders Research Unit and Associate Clinical Director of the Laboratory of Molecular Pathophysiology at the National Institute of Mental Health. Dr. Zarate received his medical degree at the Catholic University of Cordoba, Argentina.He completed his residency in adult psychiatry at the Massachusetts Mental Health Center/Brockton VA training program.

      He is recognized as a local, national and international expert in the pharmacological treatment and research of bipolar disorders and other mood disorders. He has been the principal investigator of over 30 double-blind trials in mood disorders. These trials were conducted at both the New and Experimental Therapeutic Clinic at McLean Hospital of the Consolidated Department of Psychiatry, Harvard Medical School and at the University of Massachusetts Medical School. Dr. Zarate completed a Fellowship in Clinical Psychopharmacology at McLean Hospital from 1992-1993, after which he remained as a staff member until 1998. At McLean Hospital, Dr. Zarate was the Director of the Bipolar and Psychotic Disorders Outpatient Services, Chair of the Pharmacy and Therapeutic Committee, Director of the New and Experimental Clinic, and member of numerous committees that include the Institutional Review Board, Medication Error Task Force, Continuous Medical Education Committee, Seclusion and Restraint Task Force, Continuous Quality Improvement Team and Medical Records Committee.

      From 1998 to 2000 Dr. Zarate was the Chief of the Bipolar and Psychotic Disorders Program, Associate Professor of Psychiatry and Chair of the Grand Rounds Committee at the University of Massachusetts Medical School. In January 2001, he joined the Mood and Anxiety Disorders Program at the National Institute of Mental Health. His achievements have been recognized by many different committees and he has received many awards on a local and national level including the Andrew P. Merrill Award, McLean Hospital; Ethel-Dupont Warren Award and Livingston Award, Consolidated Department of Psychiatry, Harvard Medical School; Outstanding Psychiatrist Research Award, Massachusetts Psychiatric Association; Program for Minority Research Training in Psychiatry (National Research Service Award); National Institute of Health-National Institute of Mental Health Travel Award, 1994; American College of Neuropsychopharmacology Travel Awards 1994 and 1995; and the National Alliance for Research on Schizophrenia and Depression Award, 1996-1998.

      He has published extensively on the epidemiology and treatment of bipolar disorder. His research interests include outcome of first-episode mania, the use of atypical antipsychotic drugs in bipolar disorder, and treatment-resistant mania. He is a member of the American Psychiatric Association and sits as a member on the Program for Minority Research Training Committee.

Mission Statement

Program Director

Clinical Research Opportunities

Investigators

Program Information

What's New?

Disclaimer

For further information call toll free:
1-866-MAPNIMH
1-866-627-6464